| The sixth visual object tracking vot2018 challenge results M Kristan, A Leonardis, J Matas, M Felsberg, R Pflugfelder, ... Proceedings of the European conference on computer vision (ECCV) workshops, 0-0, 2018 | 914 | 2018 |
| Tree of life for the genera of Chinese vascular plants ZD Chen, T Yang, L Lin, LM Lu, HL Li, M Sun, B Liu, M Chen, YT Niu, ... Journal of Systematics and Evolution 54 (4), 277-306, 2016 | 108 | 2016 |
| 3, 5-Disubstituted-thiazolidine-2, 4-dione analogs as anticancer agents: design, synthesis and biological characterization K Liu, W Rao, H Parikh, Q Li, TL Guo, S Grant, GE Kellogg, S Zhang European journal of medicinal chemistry 47, 125-137, 2012 | 108 | 2012 |
| Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives M Lv, Z Chen, G Hu, Q Li Drug Discovery Today 20 (3), 332-346, 2015 | 98 | 2015 |
| Novel anticancer targets and drug discovery in post genomic age Q Li, W Xu Current Medicinal Chemistry-Anti-Cancer Agents 5 (1), 53-63, 2005 | 85 | 2005 |
| The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy Z Yu, S Ye, G Hu, M Lv, Z Tu, K Zhou, Q Li Future medicinal chemistry 7 (3), 269-289, 2015 | 78 | 2015 |
| Progress in the development of aminopeptidase N (APN/CD13) inhibitors W Xu, Q Li Current Medicinal Chemistry-Anti-Cancer Agents 5 (3), 281-301, 2005 | 57 | 2005 |
| Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells SX Cui, XJ Qu, ZH Gao, YS Zhang, XF Zhang, CR Zhao, WF Xu, QB Li, ... Cancer letters 292 (2), 153-162, 2010 | 54 | 2010 |
| Structure–activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2, 4-dione: Development of potential substrate-specific ERK1/2 inhibitors Q Li, A Al-Ayoubi, T Guo, H Zheng, A Sarkar, T Nguyen, ST Eblen, S Grant, ... Bioorganic & medicinal chemistry letters 19 (21), 6042-6046, 2009 | 51 | 2009 |
| Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2, 4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways Q Li, J Wu, H Zheng, K Liu, TL Guo, Y Liu, ST Eblen, S Grant, S Zhang Bioorganic & medicinal chemistry letters 20 (15), 4526-4530, 2010 | 44 | 2010 |
| Synthesis and structure–activity relationship of 5-substituent-2 (1H)-pyridone derivatives as anti-fibrosis agents J Chen, MM Lu, B Liu, Z Chen, QB Li, LJ Tao, GY Hu Bioorganic & medicinal chemistry letters 22 (6), 2300-2302, 2012 | 43 | 2012 |
| Soluble guanylate cyclase stimulators and activators: where are we and where to go? S Xiao, Q Li, L Hu, Z Yu, J Yang, Q Chang, Z Chen, G Hu Mini reviews in medicinal chemistry 19 (18), 1544-1557, 2019 | 32 | 2019 |
| In situ synthesis of V8C7 nanopowders from a new precursor H Lin, BW Tao, Q Li, YR Li International Journal of Refractory Metals and Hard Materials 31, 138-140, 2012 | 29 | 2012 |
| Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II Q Li, H Fang, X Wang, W Xu European journal of medicinal chemistry 45 (4), 1618-1626, 2010 | 28 | 2010 |
| Novel 3-galloylamido-N′-substituted-2, 6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors Q Li, H Fang, W Xu Bioorganic & medicinal chemistry letters 17 (10), 2935-2938, 2007 | 27 | 2007 |
| Direct measurement of the cross sections for Formula Not Shown, Formula Not Shown and Formula Not Shown production by Formula Not Shown annihilation at the center-of-mass … M Ablikim, JZ Bai, Y Ban, JG Bian, X Cai, HF Chen, HS Chen, HX Chen, ... Nuclear physics B 727 (1), 395-405, 2005 | 24 | 2005 |
| Discovery of Novel Pyrazolo[3,4-b] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary … L Hu, L Li, Q Chang, S Fu, J Qin, Z Chen, X Li, Q Liu, G Hu, Q Li Journal of Medicinal Chemistry 63 (19), 11215-11234, 2020 | 22 | 2020 |
| Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I Q Li, H Fang, X Wang, L Hu, W Xu European journal of medicinal chemistry 44 (12), 4819-4825, 2009 | 21 | 2009 |
| Discovery of a dual tubulin polymerization and cell division cycle 20 homologue inhibitor via structural modification on apcin P Huang, X Le, F Huang, J Yang, H Yang, J Ma, G Hu, Q Li, Z Chen Journal of Medicinal Chemistry 63 (9), 4685-4700, 2020 | 19 | 2020 |
| Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors J Ma, H Chen, J Yang, Z Yu, P Huang, H Yang, B Zheng, R Liu, Q Li, G Hu, ... Bioorganic & Medicinal Chemistry 27 (9), 1871-1881, 2019 | 19 | 2019 |
